Spyre Therapeutics (SYRE) Depreciation & Amortization (CF) (2015 - 2023)
Spyre Therapeutics' Depreciation & Amortization (CF) was $744,000 in FY2023, down 52.5% from $1.57 million in FY2022.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Depreciation & Amortization (CF) (2015 - 2023) Analysis & Trends
From FY2014 onward, Spyre Therapeutics has reported Depreciation & Amortization (CF) for 10 years.
- Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 19.9% (FY2018 to FY2023).
- The FY2023 figure marks the lowest annual Depreciation & Amortization (CF) since FY2019.
- Per Business Quant data, Depreciation & Amortization (CF) in earlier years was $1.57 million in FY2022 (-0.6%), $1.58 million in FY2021 (+58.2%), $996,000 in FY2020 (+138.3%) and $418,000 in FY2019 (+39.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 545.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 192.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 726.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.61 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.12 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 132.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.58 Bn |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 360,000.00 |
| Mar 31, 2023 | 384,000.00 |
| Dec 31, 2022 | 385,000.00 |
| Sep 30, 2022 | 401,000.00 |
| Jun 30, 2022 | 378,000.00 |
| Mar 31, 2022 | 403,000.00 |
| Dec 31, 2021 | 411,000.00 |
| Sep 30, 2021 | 412,000.00 |
| Jun 30, 2021 | 398,000.00 |
| Mar 31, 2021 | 355,000.00 |
| Dec 31, 2020 | 369,000.00 |
| Sep 30, 2020 | 251,000.00 |
| Jun 30, 2020 | 222,000.00 |
| Mar 31, 2020 | 154,000.00 |
| Dec 31, 2019 | 106,000.00 |
| Sep 30, 2019 | 105,000.00 |
| Jun 30, 2019 | 107,000.00 |
| Mar 31, 2019 | 100,000.00 |
| Dec 31, 2018 | 79,000.00 |
| Sep 30, 2018 | 76,000.00 |
API Access
Spyre Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();